Now that we have the 20 million dollar credit line, Gerald stated in his blog that we're in a position to do things we couldn't do before. He continues to state his intention to up list ASAP. He states we will not do a RS down at these price levels. To get our price up to a more appropriate level for a RS and up listing, he offered this very interesting statement: "We will now begin contemplating shareholder value-building strategic decisions regarding certain key assets, and the best way to MONETIZE THE WORK WE ARE DOING, while keeping a view on long term value creation via our holding company business strategy." I think Gerald is now ready to "contemplate" things to pop up our pps that he wasn't willing to do before, because it might have sacrificed too much value in the long run. Obviously, he and his Advisors have some things in mind, things they knew about before but weren't willing to seriously "contemplate." But now with 4 million in cash and a 20 million credit line, perhaps the powder they have been keeping dry will finally be put to good use! I think Gerald will pull out all the stops to up list by July. I don't believe he will do it unless we are over .20 cents. Let the games begin!!
I think there are plans to get it well beyond 0.20. I think we will see a global/international partnership for Lympro that will fund MANF efforts and going it 'alone' (for now, while it is easier) for Lympro in the US. Once FDA approved, I could see a partner in the US paying a large sum to get in. Prior to that time, AMBS can leverage the CLIA sales themselves.
bhuston: I guess you forgot about AMBS announcing yesterday that we secured a 20 million line of credit. I call that pretty good news. I'm actually surprised you're still around here, based on the negative posts you've been making. Whenever I get disgusted with a stock, I sell it and buy something I believe in. However, I am not a soft basher flipping artist. Maybe you are?